Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11608376 Tumor-targeted agonistic CD28 antigen binding molecules

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 19, 2019
0
Date of Patent
March 21, 2023
0
Patent Application Number
16721272
0
Patent Citations
‌
US Patent 10253110 Anti-FAP antibodies and methods of use
0
‌
US Patent 10184009 Mutant interleukin-2 polypeptides
0
‌
US Patent 10464981 Tumor necrosis factor (TNF) family ligand trimer-containing antigen binding molecules
0
‌
US Patent 10323098 Mutant interleukin-2 polypeptides
0
‌
US Patent 10392445 Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules
0
‌
US Patent 10316104 Immunoconjugates
0
‌
US Patent 10202464 Immunoconjugates
0
‌
US Patent 10577429 Anti-FAP antibodies and methods of use
0
‌
US Patent 10603360 Combination IL-2 immunoconjugate therapy
0
‌
US Patent 10526413 Bispecific antibodies specific for OX40
0
•••
Patent Inventor Names
Tanja Fauti
0
Thomas Hofer
0
Christian Klein
0
Ekkehard Moessner
0
Guy Georges
0
Jean-Baptiste Vallier
0
Jenny Thom
0
Johannes Sam
0
Pablo Umaña
0
Ralf Hosse
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11608376
0
Patent Primary Examiner
‌
Hong Sang
0
CPC Code
‌
C07K 16/2818
0
‌
C07K 2317/31
0
‌
C07K 2317/55
0
‌
C07K 16/286
0
‌
C07K 16/2878
0
‌
C07K 16/30
0
‌
C07K 16/3007
0
‌
C07K 16/40
0
‌
C07K 16/32
0
‌
C07K 2317/52
0
•••

Find more entities like US Patent 11608376 Tumor-targeted agonistic CD28 antigen binding molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo